Group One Trading, L.P. Celularity Inc Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.56 - $1.15 $6,452 - $13,251	-11,523 Reduced 23.04%	38,487 $23,000
Q4 2022 Feb 09, 2023	BUY	$1.08 - $2.35 $30,429 - $66,211	28,175 Added 129.04%	50,010 $64,000
Q3 2022 Nov 09, 2022	BUY	$0.43 - $4.31 $9,389 - $94,108	21,835 New	21,835 $50,000
Q4 2021 Feb 11, 2022	SELL	$4.64 - $7.46 $98,595 - $158,517	-21,249 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.05 - $12.15 $128,556 - $258,175	21,249 New	21,249 $150,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.